Global Lung Disease Therapeutic Drug Supply, Demand and Key Producers, 2023-2029

February 2023 | 110 pages | ID: G9DD88FDC03DEN
GlobalInfoResearch

Abstracts

The global Lung Disease Therapeutic Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Lung Disease Therapeutic Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Lung Disease Therapeutic Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Disease Therapeutic Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Lung Disease Therapeutic Drug total production and demand, 2018-2029, (K Units)

Global Lung Disease Therapeutic Drug total production value, 2018-2029, (USD Million)

Global Lung Disease Therapeutic Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Lung Disease Therapeutic Drug consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Lung Disease Therapeutic Drug domestic production, consumption, key domestic manufacturers and share

Global Lung Disease Therapeutic Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Lung Disease Therapeutic Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Lung Disease Therapeutic Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Lung Disease Therapeutic Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals and Cipla, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Lung Disease Therapeutic Drug market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Lung Disease Therapeutic Drug Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Lung Disease Therapeutic Drug Market, Segmentation by Type

• Corticosteroids
• Bronchodilator Medications
• Mucolytics
• Antimicrobial Medications
• Others

Global Lung Disease Therapeutic Drug Market, Segmentation by Application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Companies Profiled:

• GSK
• AstraZeneca
• Boehringer Ingelheim
• Novartis
• Mylan
• Vertex Pharmaceuticals
• F. Hoffman La Roche
• Teva Pharmaceuticals
• Cipla
• Fibrogen
• Liminal Biosciences
• PharmAkea Therapeutics
• IQVIA

Key Questions Answered

1. How big is the global Lung Disease Therapeutic Drug market?

2. What is the demand of the global Lung Disease Therapeutic Drug market?

3. What is the year over year growth of the global Lung Disease Therapeutic Drug market?

4. What is the production and production value of the global Lung Disease Therapeutic Drug market?

5. Who are the key producers in the global Lung Disease Therapeutic Drug market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Lung Disease Therapeutic Drug Introduction
1.2 World Lung Disease Therapeutic Drug Supply & Forecast
  1.2.1 World Lung Disease Therapeutic Drug Production Value (2018 & 2022 & 2029)
  1.2.2 World Lung Disease Therapeutic Drug Production (2018-2029)
  1.2.3 World Lung Disease Therapeutic Drug Pricing Trends (2018-2029)
1.3 World Lung Disease Therapeutic Drug Production by Region (Based on Production Site)
  1.3.1 World Lung Disease Therapeutic Drug Production Value by Region (2018-2029)
  1.3.2 World Lung Disease Therapeutic Drug Production by Region (2018-2029)
  1.3.3 World Lung Disease Therapeutic Drug Average Price by Region (2018-2029)
  1.3.4 North America Lung Disease Therapeutic Drug Production (2018-2029)
  1.3.5 Europe Lung Disease Therapeutic Drug Production (2018-2029)
  1.3.6 China Lung Disease Therapeutic Drug Production (2018-2029)
  1.3.7 Japan Lung Disease Therapeutic Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Lung Disease Therapeutic Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Lung Disease Therapeutic Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Lung Disease Therapeutic Drug Demand (2018-2029)
2.2 World Lung Disease Therapeutic Drug Consumption by Region
  2.2.1 World Lung Disease Therapeutic Drug Consumption by Region (2018-2023)
  2.2.2 World Lung Disease Therapeutic Drug Consumption Forecast by Region (2024-2029)
2.3 United States Lung Disease Therapeutic Drug Consumption (2018-2029)
2.4 China Lung Disease Therapeutic Drug Consumption (2018-2029)
2.5 Europe Lung Disease Therapeutic Drug Consumption (2018-2029)
2.6 Japan Lung Disease Therapeutic Drug Consumption (2018-2029)
2.7 South Korea Lung Disease Therapeutic Drug Consumption (2018-2029)
2.8 ASEAN Lung Disease Therapeutic Drug Consumption (2018-2029)
2.9 India Lung Disease Therapeutic Drug Consumption (2018-2029)

3 WORLD LUNG DISEASE THERAPEUTIC DRUG MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Lung Disease Therapeutic Drug Production Value by Manufacturer (2018-2023)
3.2 World Lung Disease Therapeutic Drug Production by Manufacturer (2018-2023)
3.3 World Lung Disease Therapeutic Drug Average Price by Manufacturer (2018-2023)
3.4 Lung Disease Therapeutic Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Lung Disease Therapeutic Drug Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Lung Disease Therapeutic Drug in 2022
  3.5.3 Global Concentration Ratios (CR8) for Lung Disease Therapeutic Drug in 2022
3.6 Lung Disease Therapeutic Drug Market: Overall Company Footprint Analysis
  3.6.1 Lung Disease Therapeutic Drug Market: Region Footprint
  3.6.2 Lung Disease Therapeutic Drug Market: Company Product Type Footprint
  3.6.3 Lung Disease Therapeutic Drug Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Lung Disease Therapeutic Drug Production Value Comparison
  4.1.1 United States VS China: Lung Disease Therapeutic Drug Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Lung Disease Therapeutic Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Lung Disease Therapeutic Drug Production Comparison
  4.2.1 United States VS China: Lung Disease Therapeutic Drug Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Lung Disease Therapeutic Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Lung Disease Therapeutic Drug Consumption Comparison
  4.3.1 United States VS China: Lung Disease Therapeutic Drug Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Lung Disease Therapeutic Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Lung Disease Therapeutic Drug Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Lung Disease Therapeutic Drug Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023)
4.5 China Based Lung Disease Therapeutic Drug Manufacturers and Market Share
  4.5.1 China Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Lung Disease Therapeutic Drug Production Value (2018-2023)
  4.5.3 China Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023)
4.6 Rest of World Based Lung Disease Therapeutic Drug Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Lung Disease Therapeutic Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Corticosteroids
  5.2.2 Bronchodilator Medications
  5.2.3 Mucolytics
  5.2.4 Antimicrobial Medications
  5.2.5 Others
5.3 Market Segment by Type
  5.3.1 World Lung Disease Therapeutic Drug Production by Type (2018-2029)
  5.3.2 World Lung Disease Therapeutic Drug Production Value by Type (2018-2029)
  5.3.3 World Lung Disease Therapeutic Drug Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Lung Disease Therapeutic Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital Pharmacies
  6.2.2 Retail Pharmacies
  6.2.3 Online Pharmacies
6.3 Market Segment by Application
  6.3.1 World Lung Disease Therapeutic Drug Production by Application (2018-2029)
  6.3.2 World Lung Disease Therapeutic Drug Production Value by Application (2018-2029)
  6.3.3 World Lung Disease Therapeutic Drug Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 GSK
  7.1.1 GSK Details
  7.1.2 GSK Major Business
  7.1.3 GSK Lung Disease Therapeutic Drug Product and Services
  7.1.4 GSK Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 GSK Recent Developments/Updates
  7.1.6 GSK Competitive Strengths & Weaknesses
7.2 AstraZeneca
  7.2.1 AstraZeneca Details
  7.2.2 AstraZeneca Major Business
  7.2.3 AstraZeneca Lung Disease Therapeutic Drug Product and Services
  7.2.4 AstraZeneca Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 AstraZeneca Recent Developments/Updates
  7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Details
  7.3.2 Boehringer Ingelheim Major Business
  7.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Product and Services
  7.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Boehringer Ingelheim Recent Developments/Updates
  7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Novartis
  7.4.1 Novartis Details
  7.4.2 Novartis Major Business
  7.4.3 Novartis Lung Disease Therapeutic Drug Product and Services
  7.4.4 Novartis Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Novartis Recent Developments/Updates
  7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Mylan
  7.5.1 Mylan Details
  7.5.2 Mylan Major Business
  7.5.3 Mylan Lung Disease Therapeutic Drug Product and Services
  7.5.4 Mylan Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Mylan Recent Developments/Updates
  7.5.6 Mylan Competitive Strengths & Weaknesses
7.6 Vertex Pharmaceuticals
  7.6.1 Vertex Pharmaceuticals Details
  7.6.2 Vertex Pharmaceuticals Major Business
  7.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product and Services
  7.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Vertex Pharmaceuticals Recent Developments/Updates
  7.6.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
7.7 F. Hoffman La Roche
  7.7.1 F. Hoffman La Roche Details
  7.7.2 F. Hoffman La Roche Major Business
  7.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Product and Services
  7.7.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 F. Hoffman La Roche Recent Developments/Updates
  7.7.6 F. Hoffman La Roche Competitive Strengths & Weaknesses
7.8 Teva Pharmaceuticals
  7.8.1 Teva Pharmaceuticals Details
  7.8.2 Teva Pharmaceuticals Major Business
  7.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Product and Services
  7.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Teva Pharmaceuticals Recent Developments/Updates
  7.8.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Cipla
  7.9.1 Cipla Details
  7.9.2 Cipla Major Business
  7.9.3 Cipla Lung Disease Therapeutic Drug Product and Services
  7.9.4 Cipla Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Cipla Recent Developments/Updates
  7.9.6 Cipla Competitive Strengths & Weaknesses
7.10 Fibrogen
  7.10.1 Fibrogen Details
  7.10.2 Fibrogen Major Business
  7.10.3 Fibrogen Lung Disease Therapeutic Drug Product and Services
  7.10.4 Fibrogen Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Fibrogen Recent Developments/Updates
  7.10.6 Fibrogen Competitive Strengths & Weaknesses
7.11 Liminal Biosciences
  7.11.1 Liminal Biosciences Details
  7.11.2 Liminal Biosciences Major Business
  7.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Product and Services
  7.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Liminal Biosciences Recent Developments/Updates
  7.11.6 Liminal Biosciences Competitive Strengths & Weaknesses
7.12 PharmAkea Therapeutics
  7.12.1 PharmAkea Therapeutics Details
  7.12.2 PharmAkea Therapeutics Major Business
  7.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Product and Services
  7.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 PharmAkea Therapeutics Recent Developments/Updates
  7.12.6 PharmAkea Therapeutics Competitive Strengths & Weaknesses
7.13 IQVIA
  7.13.1 IQVIA Details
  7.13.2 IQVIA Major Business
  7.13.3 IQVIA Lung Disease Therapeutic Drug Product and Services
  7.13.4 IQVIA Lung Disease Therapeutic Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.13.5 IQVIA Recent Developments/Updates
  7.13.6 IQVIA Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Lung Disease Therapeutic Drug Industry Chain
8.2 Lung Disease Therapeutic Drug Upstream Analysis
  8.2.1 Lung Disease Therapeutic Drug Core Raw Materials
  8.2.2 Main Manufacturers of Lung Disease Therapeutic Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Lung Disease Therapeutic Drug Production Mode
8.6 Lung Disease Therapeutic Drug Procurement Model
8.7 Lung Disease Therapeutic Drug Industry Sales Model and Sales Channels
  8.7.1 Lung Disease Therapeutic Drug Sales Model
  8.7.2 Lung Disease Therapeutic Drug Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Lung Disease Therapeutic Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Lung Disease Therapeutic Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Lung Disease Therapeutic Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Lung Disease Therapeutic Drug Production Value Market Share by Region (2018-2023)
Table 5. World Lung Disease Therapeutic Drug Production Value Market Share by Region (2024-2029)
Table 6. World Lung Disease Therapeutic Drug Production by Region (2018-2023) & (K Units)
Table 7. World Lung Disease Therapeutic Drug Production by Region (2024-2029) & (K Units)
Table 8. World Lung Disease Therapeutic Drug Production Market Share by Region (2018-2023)
Table 9. World Lung Disease Therapeutic Drug Production Market Share by Region (2024-2029)
Table 10. World Lung Disease Therapeutic Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Lung Disease Therapeutic Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Lung Disease Therapeutic Drug Major Market Trends
Table 13. World Lung Disease Therapeutic Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Lung Disease Therapeutic Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Lung Disease Therapeutic Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Lung Disease Therapeutic Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Lung Disease Therapeutic Drug Producers in 2022
Table 18. World Lung Disease Therapeutic Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Lung Disease Therapeutic Drug Producers in 2022
Table 20. World Lung Disease Therapeutic Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Lung Disease Therapeutic Drug Company Evaluation Quadrant
Table 22. World Lung Disease Therapeutic Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Lung Disease Therapeutic Drug Production Site of Key Manufacturer
Table 24. Lung Disease Therapeutic Drug Market: Company Product Type Footprint
Table 25. Lung Disease Therapeutic Drug Market: Company Product Application Footprint
Table 26. Lung Disease Therapeutic Drug Competitive Factors
Table 27. Lung Disease Therapeutic Drug New Entrant and Capacity Expansion Plans
Table 28. Lung Disease Therapeutic Drug Mergers & Acquisitions Activity
Table 29. United States VS China Lung Disease Therapeutic Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Lung Disease Therapeutic Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Lung Disease Therapeutic Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Lung Disease Therapeutic Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Lung Disease Therapeutic Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Lung Disease Therapeutic Drug Production Market Share (2018-2023)
Table 37. China Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Lung Disease Therapeutic Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Lung Disease Therapeutic Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Lung Disease Therapeutic Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Lung Disease Therapeutic Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production Market Share (2018-2023)
Table 47. World Lung Disease Therapeutic Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Lung Disease Therapeutic Drug Production by Type (2018-2023) & (K Units)
Table 49. World Lung Disease Therapeutic Drug Production by Type (2024-2029) & (K Units)
Table 50. World Lung Disease Therapeutic Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Lung Disease Therapeutic Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Lung Disease Therapeutic Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Lung Disease Therapeutic Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Lung Disease Therapeutic Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Lung Disease Therapeutic Drug Production by Application (2018-2023) & (K Units)
Table 56. World Lung Disease Therapeutic Drug Production by Application (2024-2029) & (K Units)
Table 57. World Lung Disease Therapeutic Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Lung Disease Therapeutic Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Lung Disease Therapeutic Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Lung Disease Therapeutic Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Lung Disease Therapeutic Drug Product and Services
Table 64. GSK Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Lung Disease Therapeutic Drug Product and Services
Table 70. AstraZeneca Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Ingelheim Major Business
Table 75. Boehringer Ingelheim Lung Disease Therapeutic Drug Product and Services
Table 76. Boehringer Ingelheim Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Lung Disease Therapeutic Drug Product and Services
Table 82. Novartis Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Mylan Basic Information, Manufacturing Base and Competitors
Table 86. Mylan Major Business
Table 87. Mylan Lung Disease Therapeutic Drug Product and Services
Table 88. Mylan Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Mylan Recent Developments/Updates
Table 90. Mylan Competitive Strengths & Weaknesses
Table 91. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Vertex Pharmaceuticals Major Business
Table 93. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product and Services
Table 94. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Vertex Pharmaceuticals Recent Developments/Updates
Table 96. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. F. Hoffman La Roche Basic Information, Manufacturing Base and Competitors
Table 98. F. Hoffman La Roche Major Business
Table 99. F. Hoffman La Roche Lung Disease Therapeutic Drug Product and Services
Table 100. F. Hoffman La Roche Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffman La Roche Recent Developments/Updates
Table 102. F. Hoffman La Roche Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceuticals Major Business
Table 105. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product and Services
Table 106. Teva Pharmaceuticals Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Teva Pharmaceuticals Recent Developments/Updates
Table 108. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Cipla Basic Information, Manufacturing Base and Competitors
Table 110. Cipla Major Business
Table 111. Cipla Lung Disease Therapeutic Drug Product and Services
Table 112. Cipla Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Cipla Recent Developments/Updates
Table 114. Cipla Competitive Strengths & Weaknesses
Table 115. Fibrogen Basic Information, Manufacturing Base and Competitors
Table 116. Fibrogen Major Business
Table 117. Fibrogen Lung Disease Therapeutic Drug Product and Services
Table 118. Fibrogen Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Fibrogen Recent Developments/Updates
Table 120. Fibrogen Competitive Strengths & Weaknesses
Table 121. Liminal Biosciences Basic Information, Manufacturing Base and Competitors
Table 122. Liminal Biosciences Major Business
Table 123. Liminal Biosciences Lung Disease Therapeutic Drug Product and Services
Table 124. Liminal Biosciences Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Liminal Biosciences Recent Developments/Updates
Table 126. Liminal Biosciences Competitive Strengths & Weaknesses
Table 127. PharmAkea Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. PharmAkea Therapeutics Major Business
Table 129. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product and Services
Table 130. PharmAkea Therapeutics Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. PharmAkea Therapeutics Recent Developments/Updates
Table 132. IQVIA Basic Information, Manufacturing Base and Competitors
Table 133. IQVIA Major Business
Table 134. IQVIA Lung Disease Therapeutic Drug Product and Services
Table 135. IQVIA Lung Disease Therapeutic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Lung Disease Therapeutic Drug Upstream (Raw Materials)
Table 137. Lung Disease Therapeutic Drug Typical Customers
Table 138. Lung Disease Therapeutic Drug Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. Lung Disease Therapeutic Drug Picture
Figure 2. World Lung Disease Therapeutic Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Lung Disease Therapeutic Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Lung Disease Therapeutic Drug Production (2018-2029) & (K Units)
Figure 5. World Lung Disease Therapeutic Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Lung Disease Therapeutic Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Lung Disease Therapeutic Drug Production Market Share by Region (2018-2029)
Figure 8. North America Lung Disease Therapeutic Drug Production (2018-2029) & (K Units)
Figure 9. Europe Lung Disease Therapeutic Drug Production (2018-2029) & (K Units)
Figure 10. China Lung Disease Therapeutic Drug Production (2018-2029) & (K Units)
Figure 11. Japan Lung Disease Therapeutic Drug Production (2018-2029) & (K Units)
Figure 12. Lung Disease Therapeutic Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 15. World Lung Disease Therapeutic Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 17. China Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 22. India Lung Disease Therapeutic Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Lung Disease Therapeutic Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Lung Disease Therapeutic Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Lung Disease Therapeutic Drug Markets in 2022
Figure 26. United States VS China: Lung Disease Therapeutic Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Lung Disease Therapeutic Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Lung Disease Therapeutic Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Lung Disease Therapeutic Drug Production Market Share 2022
Figure 30. China Based Manufacturers Lung Disease Therapeutic Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Lung Disease Therapeutic Drug Production Market Share 2022
Figure 32. World Lung Disease Therapeutic Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Lung Disease Therapeutic Drug Production Value Market Share by Type in 2022
Figure 34. Corticosteroids
Figure 35. Bronchodilator Medications
Figure 36. Mucolytics
Figure 37. Antimicrobial Medications
Figure 38. Others
Figure 39. World Lung Disease Therapeutic Drug Production Market Share by Type (2018-2029)
Figure 40. World Lung Disease Therapeutic Drug Production Value Market Share by Type (2018-2029)
Figure 41. World Lung Disease Therapeutic Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Lung Disease Therapeutic Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Lung Disease Therapeutic Drug Production Value Market Share by Application in 2022
Figure 44. Hospital Pharmacies
Figure 45. Retail Pharmacies
Figure 46. Online Pharmacies
Figure 47. World Lung Disease Therapeutic Drug Production Market Share by Application (2018-2029)
Figure 48. World Lung Disease Therapeutic Drug Production Value Market Share by Application (2018-2029)
Figure 49. World Lung Disease Therapeutic Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Lung Disease Therapeutic Drug Industry Chain
Figure 51. Lung Disease Therapeutic Drug Procurement Model
Figure 52. Lung Disease Therapeutic Drug Sales Model
Figure 53. Lung Disease Therapeutic Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source